Introduction of the JACIE standard in the PBPC collection facility

Peripheral blood progenitor cells (PBPC) are used to support patients through high-dose therapy procedures. An infusion of autologous PBPC following high-dose chemo- or chemoradiotherapy greatly shortens the period of pancytopenia experienced by the patient, and therefore substantially lessens the risks of morbidity and mortality that would otherwise ensue from a very prolonged period of severe neutropenia and thrombocytopenia...